HOLLENBACH; Paul

Patent Applications and Registrations

Patent applications and USPTO patent grants for HOLLENBACH; Paul.The latest application filed is for "methods for determining drug efficacy for the treatment of diffuse large b-cell lymphoma, multiple myeloma, and myeloid cancers".

Company Profile

5.2.7

HOLLENBACH; Paul - Castro Valley CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods For Determining Drug Efficacy For The Treatment Of Diffuse Large B-cell Lymphoma, Multiple Myeloma, And Myeloid Cancers App 20220003749 - TROTTER; Matthew William Burnell ; et al.	2022-01-06
Treatment Of A Hematologic Malignancy With 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)m- Ethyl)-2,2-difluoroacetamide App 20210154182 - Carrancio; Soraya ; et al.	2021-05-27
Methods for determining drug efficacy for the treatment of diffuse large B-cell lymphoma, multiple myeloma, and myeloid cancers Grant 10,996,215 - Trotter , et al. May 4, 2	2021-05-04
Treatment Of A Hematologic Malignancy With 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)m- Ethyl)-2,2 App 20190175573 - Carrancio; Soraya ; et al.	2019-06-13
Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)m- ethyl)-2,2-difluoroacetamide Grant 10,245,258 - Carrancio , et al.	2019-04-02
Methods For Determining Drug Efficacy For The Treatment Of Diffuse Large B-cell Lymphoma, Multiple Myeloma, And Myeloid Cancers App 20190004033 - TROTTER; Matthew William Burnell ; et al.	2019-01-03
Treatment Of A Hematologic Malignancy With 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)m- Ethyl)-2,2-difluoroacetamide App 20170348298 - Carrancio; Soraya ; et al.	2017-12-07
Methods For Determining Drug Efficacy For The Treatment Of Diffuse Large B-cell Lymphoma, Multiple Myeloma, And Myeloid Cancers App 20160313300 - Trotter; Matthew William Burnell ; et al.	2016-10-27
Treatment Of Melanoma App 20100086518 - Heise; Carla C. ; et al.	2010-04-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.